HomeINBX • NASDAQ
add
Inhibrx Biosciences Inc
Previous close
$15.26
Day range
$14.91 - $15.47
Year range
$10.80 - $39.79
Market cap
221.01M USD
Avg Volume
63.44K
P/E ratio
0.13
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.90M | 0.19% |
Net income | -43.86M | 15.30% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -46.04M | -1.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 196.33M | — |
Total assets | 222.56M | — |
Total liabilities | 44.10M | — |
Total equity | 178.47M | — |
Shares outstanding | 14.48M | — |
Price to book | 1.24 | — |
Return on assets | -48.65% | — |
Return on capital | -58.23% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -43.86M | 15.30% |
Cash from operations | -30.28M | 44.18% |
Cash from investing | -247.00K | 69.54% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -30.53M | -121.08% |
Free cash flow | -16.31M | — |
About
Founded
2024
Headquarters
Website
Employees
173
